|
Microarray cohort
(n=35) |
|
PCR cohort
(n=45) |
|
|
Good outcome (n=21) |
Bad outcome (n=14) |
P |
Good outcome (n=27) |
Bad outcome (n=18) |
P |
Age (years) |
61.3±11.2 |
66.4±8.5 |
0.16 |
59.9±10.4 |
65.1±8.7 |
0.11 |
Male (n) |
18 (85%) |
9 (64%) |
0.14 |
24 (89%) |
11 (61%) |
0.03 |
Initial rhythm |
|
|
0.04 |
|
|
0.02 |
VF/VT |
18 (86%) |
6 (43%) |
|
24 (89%) |
9 (50%) |
|
Asystole |
1 (5%) |
6 (43%) |
|
1 (4%) |
7 (39%) |
|
PEA |
2 (9%) |
2 (14%) |
|
2 (7%) |
2 (11%) |
|
Time to ALS (min) |
9±7 |
14±9 |
0.06 |
8±7 |
12±9 |
0.11 |
Time to defib (min) |
10±7 |
15±8 |
0.09 |
9±7 |
12±8 |
0.14 |
Time to ROSC (min) |
20 [14-29] |
30[28-30] |
0.008 |
20[12-30] |
30[30-36] |
<0.001 |
MI (n) |
18 (86%) |
9 (64%) |
0.14 |
24 (89%) |
13 (72%) |
0.15 |
SAPS II |
60±9 |
72±11 |
0.002 |
59±8 |
73±11 |
<0.001 |
Shock (n) |
6 (29%) |
6 (43%) |
0.89 |
6 (22%) |
10 (56%) |
0.02 |
VF/VT: ventricular fibrillation/ventricular tachycardia; PEA: pulseless electric activity; ALS: advanced life support; ROSC: return of spontaneous circulation; SAPS: simplified
acute physiology score; MI: myocardial infarction. Data are mean ± SD, medians with interquartile range, or number with percentages. |
